Browsing category:

Patent Expiration 2020


Antibiotics, such as Amoxicillin, are extremely effectual when used appropriately prior to surgical procedures. The expiration of the potent antimicrobial drug Moxatag, also known as Amoxicillin, on October 13, 2020, paves the way for additional development of this generic powerhouse. Study results recently released in Infection Control and Hospital Epidemiology reveal that timing is crucial[…]

Read More

Regorafenib is a formidable treatment for colon cancer, and in late 2013 it has received another new approval for GIST in Japan and Europe. Known as the trade name Stivarga, Regorafenib was approved in both Japan and Europe for the treatment of gastrointestinal stromal tumors. The FDA approved Regorafenib two years ago and added the[…]

Read More

Rosuvastatin Calcium, known as the brand name Crestor, has a patent expiration of August 4, 2020. Recent study data revealed that patients who received the high potency statin Rosuvastatin after a heart attack had a high survival rate. This study from the Cardiovascular division at the University of Dundee Medical School compared Ezetimibe with higher[…]

Read More

Fenofibrate, CAS number 49562-28-9, is known as the brand name Lipofen, which is marketed by Cipher-Kowa Pharmaceuticals. The patent for Lipofen is due to expire on January 10, 2015. Other recognizable brands of fenofibrate are Tricor, which has a patent expiration of January 9, 2018 and Antara, which has a patent expiration set for August[…]

Read More